Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trial.

Hoffmann AL, Troost EG, Huizenga H, Kaanders JH, Bussink J.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1596-602. doi: 10.1016/j.ijrobp.2011.10.032. Epub 2012 Jan 13.

PMID:
22245206
2.

Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.

van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, Wouters BG, Lambin P, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1103-10. doi: 10.1016/j.ijrobp.2007.11.028. Epub 2008 Feb 6.

PMID:
18258382
3.
4.

Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.

Schwarz M, Alber M, Lebesque JV, Mijnheer BJ, Damen EM.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):561-70.

PMID:
15890601
5.

Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.

Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD.

Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1087-96. Epub 2006 May 6.

PMID:
16682145
7.

Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.

Lievens Y, Nulens A, Gaber MA, Defraene G, De Wever W, Stroobants S, Van den Heuvel F; Leuven Lung Cancer Group.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):306-13. doi: 10.1016/j.ijrobp.2010.06.025. Epub 2010 Oct 1.

PMID:
20888706
8.

Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study.

van Baardwijk A, Bosmans G, Boersma L, Wanders S, Dekker A, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Lambin P, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1394-401. doi: 10.1016/j.ijrobp.2007.11.070. Epub 2008 Feb 6.

PMID:
18258380
9.

Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.

van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55.

PMID:
15708242
10.

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M.

Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29.

PMID:
18514339
11.

Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.

Meijer G, Steenhuijsen J, Bal M, De Jaeger K, Schuring D, Theuws J.

Radiother Oncol. 2011 Sep;100(3):396-401. doi: 10.1016/j.radonc.2011.08.048. Epub 2011 Sep 28.

PMID:
21955663
12.

Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.

Register SP, Zhang X, Mohan R, Chang JY.

Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1015-22. doi: 10.1016/j.ijrobp.2010.03.012. Epub 2010 Jul 7.

13.

Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.

St-Hilaire J, Sévigny C, Beaulieu F, Germain F, Lavoie C, Dagnault A, Gingras L, Tremblay D, Beaulieu L.

Radiother Oncol. 2009 Jun;91(3):342-8. doi: 10.1016/j.radonc.2008.11.017. Epub 2009 Jan 8.

PMID:
19135749
14.
15.

Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.

Gomez DR, Gillin M, Liao Z, Wei C, Lin SH, Swanick C, Alvarado T, Komaki R, Cox JD, Chang JY.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):665-70. doi: 10.1016/j.ijrobp.2013.03.035. Epub 2013 May 18.

16.

An isotoxic planning comparison study for stage II-III non-small cell lung cancer: is intensity-modulated radiotherapy the answer?

Warren M, Webster G, Ryder D, Rowbottom C, Faivre-Finn C.

Clin Oncol (R Coll Radiol). 2014 Aug;26(8):461-7. doi: 10.1016/j.clon.2014.03.011. Epub 2014 May 3.

PMID:
24793504
17.

Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.

Kelsey CR, Das S, Gu L, Dunphy FR 3rd, Ready NE, Marks LB.

Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):997-1004. doi: 10.1016/j.ijrobp.2015.09.007. Epub 2015 Sep 15.

PMID:
26581138
18.

Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.

Belderbos JS, Heemsbergen WD, De Jaeger K, Baas P, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):126-34.

PMID:
16904518
19.

First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy.

Belderbos JS, De Jaeger K, Heemsbergen WD, Seppenwoolde Y, Baas P, Boersma LJ, Lebesque JV.

Radiother Oncol. 2003 Feb;66(2):119-26.

PMID:
12648783
20.

Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer.

van Baardwijk A, Wanders S, Boersma L, Borger J, Ollers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Lunde R, Lambin P, De Ruysscher D.

J Clin Oncol. 2010 Mar 10;28(8):1380-6. doi: 10.1200/JCO.2009.24.7221. Epub 2010 Feb 8.

Items per page

Supplemental Content

Write to the Help Desk